Stockreport

Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Recursion Pharmaceuticals, Inc.'s share was trading at $4.67 as of January 16th. Wichy/Shutterstock.com Recursion Pharmaceuticals, Inc. operates as a clinical-stage [Read more]